Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Tenapanor improves symptoms in patients with IBS-C Tenapanor improves symptoms in patients with IBS-C

Tenapanor improves symptoms in patients with IBS-C

07 Jun 2022 bởiElaine Soliven

Treatment with tenapanor improves symptoms in patients with irritable bowel syndrome with constipation (IBS-C) as early as week 1 of treatment, according to two phase III studies presented at DDW 2022.

07 Jun 2022
NAFLD tied to CVD risk even in lean patients

NAFLD tied to CVD risk even in lean patients

06 Jun 2022 bởiElvira Manzano

Individuals with nonalcoholic fatty liver disease (NAFLD) – despite having a lean body or healthy BMI – are at an elevated risk for peripheral vascular disease, stroke, and cardiovascular disease (CVD), a finding that surprises gastroenterologists and researchers at DDW 2022.

06 Jun 2022
Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation

Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation

04 Jun 2022

Following discontinuation of nucleot(s)ide analogue therapy, only about one-third of patients with HBeAg-negative chronic hepatitis B (CHB) achieve disease remission, with rare HBsAg loss, as reported in a study. The likelihood of HBsAg loss and disease remission is high in the presence of very low HBsAg levels at baseline.

04 Jun 2022